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It has become increasingly clear that there are additional mechanisms to the sliding
filament theory that contribute to the contractile properties of smooth muscle. It has
been suggested that remodelling of the cytoskeleton may explain the unique
contractile properties exhibited by smooth muscle. There has been previous evidence
of differential remodeling of the alpha- and beta-actin as well as smooth muscle
myosin II cytoskeletal structures. However, the mechanism(s) regulating this
differential remodeling are not understood. Previous experiments have demonstraed
that inhibition ofRho'kinase has been ~hown to decrease force development in
contracting aortic smooth muscle tissue. We wanted to test the hypothesis that
inhibition of Rho kinase would alter alpha-actin remodeling and podosome formation
in A7r5 smooth muscle cells. A 7r5 cells stimulated with 10-8M PDBu demonstrated
remodeling of the alpha-actin cytoskeleton with a partial loss of actin cable structure
and formation of podosomes. Cells were treated with the specific Rho kinase
inhibitor Y-27632 at three different concentrations (lµM, 0.1 µM, and lnM) either

before or after stimulation with I 0-8 M phorbol ester (PDBu).

Cells treated with

Y-27632 before stimulation with PDBu did not undergo normal alpha-actin
remodeling. Podosome formation was abolished, and there was loss of actin cable
structure. In precontracted cells treated with Y-27632, podosome structure was lost
and the alpha-actin fiber structure was lost. The results indicate that the inhibition of
Rho kinase prevents remodeling of the alpha-actin cytoskeleton and may play a
significant role in smooth muscle forci; generation. To observe the effect of
inhibition Rho kinase in resting cells, A7r5 ells were exposed to lnM ofY-27632 for
5 , 10, 20, 30, and 40 minutes. After five minutes of exposure, disruption of the
a.-actin cytoskeleton was evident with an almost complete disruption of cable
stucture by 40 minutes exposure. This data suggests that Rho kinase activity is also
required for a.-actin bundling into fibers in the resting cell. Taken together it is
apparent that Rho kinase is an essential enzyme in regulating alpha-actin dynamics in
the A 7r5 smooth muscle cell.
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INTRODUCTION

'

.

This project was designed
to enhance
our understanding of possible additional
.
. ·~
mechanisms to the sliding filament theory that contributes to the unique contractile
.

~

.. '

properties of smooth muscle, by the utilizati~n of immunochemistry techniques. The
protocols have allowed us to examine the effects of inhibition of Rho kinase in
smooth muscle cell a-actin remodeling and how it could have an effect upon the
contraction of smooth muscle. This study investigated the hypothesis that inhibition
of Rho kinase will prevent a-actin reorganization in the A7r5 smooth muscle cell.
The objective of the experimental design was to determine ifby inhibition of Rho
kinase there is an affect on the organization of a-actin into podosomes.

Smooth Muscle Function

Smooth muscle tissue is found in several organ systems within the body:
gastrointestinal, reproductive, ocular, respiratory, urinary and vascular. Smooth
muscle is named for the lack of visible striations within the tissue. Functions of
smooth muscle include: controlling the diameter of blood vessels, the movement of
food along the gastrointestinal system, homeostatic function within the reproductive
tract, the ocular system, and the arrector pili in the skin. A common function of
smooth muscle is for transport or storage. It does not function as a rigid conduit for
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transport. This is illustrated through the dynamic contractile/relaxant response of
vascular smooth muscle during the regulation and maintenance of blood pressure.
Smooth muscle develops tension slowly and is capable of maintaining tension for a
long period of time (Figure 1). This is in contrast to skeletal muscle which is unable
to maintain tension for an extended period of time. The energy level that is required
to maintain tension in smooth muscle occill;l at about 0.35% of a tetanized striated
muscle (Paul, 1983).

Sliding Filament Theory

Myosin and actin are present in both smooth and skeletal muscle; both
proteins are associated in a complex structure called, actomyosin. The organization
and properties of both myosin and actin within the muscle are utilized for contraction
and relaxation of muscle, and occurs in a similar mechanism in both smooth and
skeletal muscle as described by the sliding filament theory (Marston and Smith,
1985). The sliding filament theory _describes how myosin and actin interact by a
cross-bridge formation (Figure 2). The myosin heads that project from the thick
filaments briefly attach to a binding site on an adjacent actin filament. Driven by
ATP energy strokes, myosin heads will pull the actin filament along with them
toward the center of the sarcomere. The sarcomere will shorten as the actin filaments
slide towards its center (Starr and Taggart, 2001). Although both muscle types are
signaled to contract by an increase in the intracellular calcium, the subsequent
biochemical pathways are different (Figure 2 and Figure 3).
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Smooth Muscle Contraction

3

0

----

---------------------------Skeletal Muscle Contraction

Figure 1: Typical contraction demonstrating the differences between smooth
and striated muscle.
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Increase in intracellular Calcium

Tropomyosin shifts out of Resting Position on Actin Helicies
Disinhibition of Actin Myosin Interaction
Myosin/Actin Binding
Myosin ATPase Activated
Crossbridge Formation and Cycling

Figure 2. Sliding filament theory of muscle contraction.
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Smooth Muscle Structure
Smooth muscle has a single nucleus with a wide peripheral zone of cytoplasm
which is dominated by myofilament bundles that are associated with dense bodies
(Thyberg et al., 1985). The spindle shaped cells in smooth muscle are composed of
thick and thin filaments which are not organized into well-ordered sacromeres, as
they are in skeletal muscle; thus the term smooth muscle. Thin filaments have three
functions within smooth muscle: (1) force generation by interaction with the protein
myosin (2); control of force generation by interaction with regulatory molecules (3);
and transmission of force to the ends of the cell to produce contraction of the muscle
as a whole, by organization of actin into filament arrays and attachment to the cell
surface (Marston and Smith, 1985). The thin filament is composed of a double helix
of actin monomers, with monomers repeating every 5.9 nm and the helix completing
one full turn every 74 nm (Marston and Smith, 1985). Thin filaments arrange in
parallel tracts along the cell length in the relaxed smooth muscle. The filaments
gather in loose bundles, which will attach to the dense bodies. Actin filaments may
be arranged in a dense bundle that allows for 15 actin filaments to interact with each
myosin filament in smooth muscle (Marston and Smith, 1985). In smooth muscle, the
actin-binding protein a.-actinin is present; as well as the actin binding protein
vinculin, which is not found in the Z disks in skeletal muscle. Vinculin will bind to
the integral membrane directly in the plaque and also to the a.-actinin, which then
attach to the actin filaments to the membrane adhesion sites (Alberts et al., 2002).
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The actin binding and crosslinking activities of a.-actinin are influenced strongly by
the presence of other actin binding proteins and are also temperature-dependent
(Schloss and Goldman, 1979).

Actin Cytoskeleton Dynamics ,

.

'

The actin cytoskeleton is an imporll!Jlt structure
that contributes to cell-cell
.
.
and cell-substrate interactions providing a structural framework by modulating signal
transduction cascades (Yin and Stull, 1999). It is also involved with many of the
fundamental cell processes, such as lamellipodial and growth cone extension,
chemotaxis, endocytosis, exocytosis, and cytokinesis. Adding monomers to the
barbed end of an actin nucleating site near the membrane and depolmerizing deeper
within the cytoplasm of the actin filament causes the dynamic nature of an actin
filament. This process involves the regulation of many proteins. Actin nucleation
requires additional proteins. Actin related protein, Arp2/3 will cap the pointed ends
of the actin, and initiate polymerization on the barbed end (Yin and Stull, 1999).
Proteins in the Wiskott-Aldrich syndrome protein family, (WASp) stimulate
nucleation by Arp2/3 and the small GTPase, Cdc42, and PIP2, This will then increase
the activity of some WASp proteins (Yin and Stull, 1999). Subsequently, the barbed
ends are produced by the cutting of preexisting actin filaments to create an exposed
barbed end. This may be performed by gelsolin which is an actin severing protein
activated by Ca2+. Gelsolin uncapping and barbed end elongation may be promoted
by PIP 2 and Rae. In addition, the barbed ends of actin may be exposed by the
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removal of capping proteins such as CapG (Yin and Stull, 1999). In order for rapid
actin polymerization to occur on the leading edge (the barbed end), depolymerization
must occur somewhere else to maintain the supply of G-actin monomers for addition
to the growing F-actin. ADF/cofilin promotes actin filament depolymerization by
severing and promoting actin fiber breakdown (Yin and Stull, 1999) and may provide
a pool of available actin monomers. Actin filaments which are polymerized may
form a scaffold-like structure near the plasma membrane using ERM cross-linking
proteins. The ERMs are composed of the proteins ezrin, radixin and moesin and play
an important role in organization of the cortical actin network and mediating
membrane/cytoskeletal cross-talk. The ERM proteins are activated by PIP2 through a
Rho-dependent pathway, and ERM conformation is maintained by phosphorylation
(Yin and Stull, 1999).
Polymerizable ATP-actin consists of free ATP-G-actin and complexes of
ATP-G-actin with profilin or with functional homologs of profiling like WH2-domain
proteins of the actobindin family (Carlier and Pantaloni, 2007). The WH2-domain
proteins bind with G-actin and participate in the barbed end assembly, profilin and its
functional homologs will also "play a role in the assembly. The ATP-G-actin
polymerization is determined by the overall flux of pointed end depolymerization and
by the number of barbed ends_ (Carlier and Pantaloni, 2007).
Smooth muscle contains two actin isoforms, the ~-actin filaments that are
structural, and the a-actin filaments that associate with myosin and are involved in
contraction (Yin and Stull, 1999).
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Smooth Muscle Role of Myosin

Myosin present in smooth muscle may be only 20% of skeletal muscle
(Murphy et al., 1974; Murphy 1976). Myosin containing filaments help to generate
tension that may occur during a muscle contraction. The myosin molecule appears as
a structure ranging in length to approximately 150nm long, consisting of two globular
heads and a single tail. Myosin molecules found in smooth muscle consist of six
polypeptide chains. The chains include two heavy chains, two regulatory chains, and
two essential alkali light chains. The two heavy chains will come together and form a
dimer, which comprises the main body of the molecule. The heads of the myosin
molecule will form the cross-bridges with actin. Motor activity is contained within
the head, and it is here that we find the ATP and actin binding sites. Each head
consists of a heavy chain of about 2,000 amino acids and has two light chains
attached to it (McComas 1996). There are three components of the globular head,
with the molecular weight of 20 kDa, 25 kDa, .and 50 kDa. The two light chains will
attach to the 20 kD subunit, while the 50 kDa subunit contains the ATP hydrolyzing
site, a well as sites for attachment to actin (McComas 1996). The tail is formed by
two a-helices that will coil around each other and myosin molecules will associate
together so that several hundred can form a single myosin filament. The structure of
the tail also allows for each of the myosin molecules within the filament to face away
from the other half(McComas 1996).

-9-

Myosin Light Chain Kinase
Differences in the structure and contractile protein content in both smooth and
skeletal muscle suggest that there may be mechanisms in smooth muscle in addition
to sliding filament which provides a biochemical or mechanical advantage during
smooth muscle contraction. The stimulation of smooth muscle will result in the rise
of intracellular calcium which will lead to tlie activation of the calcium binding
protein, calmodulin: Calmodulin will activate the myosin light chain kinase with the
resulting phosphorylation of Ser 19 on myosin light chains. After phosphorylation
occurs, myosin ATPase activity, and subsequent myosin/actin crossbridge formation
and cycling will occur. It has been shown that slow force development, maintenance
of tension (Driska et al., 1981 ), and velocity of shortening (Merkel et al., 1990) are
disassociated from the myosin light chain phosphorylation and myosin ATPase
activity (Zhang and Moreland, I 994) in smooth muscle. A contraction that has been
induced by phorbol ester may occur in the absence of a detectable increase of
intracellular Ca2+or concomitantly increased myosin light chain phosphorylation
(Nakajima et al., 1993). It has been shown that myosin light chains affect the actions
of the myosin heads, possibly modifying the rate of movement in each power stroke
(Nakajima et al., 1993). Phosphorylation of the myosin light chain has been proposed
as the mechanism responsible for potentiating isometric twitch tension (Nakajima et
al., 1993). Increasing Ca2+ within permeable cells will increase the extent of the
myosin light chain phosphorylation. (Figure 3).
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Increase in Intracellular Calcium

Calcium/Calmodulin Complex

Phosphloration of Myosin Light Chain Kinase (MLCK)

Phosphorylation of Serine 19 of Myosin Light Chains

Activation of Myosin ATPase
Figure 3: Traditional biochemical pathway of smooth muscle
contraction.
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Signal Transduction Pathways in Smooth Muscle
Smooth muscle cells may be able to adjust their functional properties by
reorganizing their cytoskeleton and also by altering signaling pathways which
regulate contractile protein activation and function (Gerthoffer and Gunst, 2001).
The signaling pathways seem to mediate these adaptive responses of the cytoskeleton
to be integrated with the pathways which regulate gene expression, cell phenotype,
and protein synthesis. This suggests that the immediate adaptive responses of smooth
muscle cells may proceed or initiate a modification of a longer time frame in cell
phenotype and tissue structure. Signal transduction pathways to the actin
cytoskeleton are present in differentiated smooth muscle tissues, and it is these
pathways which may be important in adapting the structural organization, phenotype,
and contractile properties of the tissues to external forces, allowing for the smooth
muscle tissues of hollow organs to respond to a changfr1g environment. Actin
remodeling is required for cell migration to occur during development and also in the
proliferative response to injury in the smooth muscle (Gerthoffer and Gunst, 2001).

Integrins
Within the smooth muscle cells, the integrins are found to be localized to
membranes associated with electron dense plaques. This is where tension
transmission between the contractile apparatus and extracellular matrix may occur
(Shaw et al., 2002). At the membrane associated dense plaques, actin filaments will
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attach to transmembrane integrins by a series of linker proteins that include talin,
vinculin, cx.-actinin, as well as various kinases and signaling proteins. Integrins and
focal adhesion proteins, including F AK, Src family tyrosine kinases and paxillin, may
function as factors in this signaling pathway (Gerthoffer and Gunst, 2001 ). The
superfamily ofras-related small G proteins can be divided into three subfamilies:
Rho, Rae, and Cdc42 [vv ang and Bitar, 1998) and may play an important role in
coupling mechanotransduction pathways to actin remodeling (Gerthoffer and Gunst,
2001).

Rho-kinase
Rho-kinases are serine/theronine kinases with a molecular mass of
approximately 160 kDa and are expressed in both invertebrates and vertebrates
(Loirand et al., 2006). The gene for Rho-kinase in humans is located on chromosome
12, and codes for a protein of 1,388 amino acids (Noma et al., 2006). Rho-kinases
are distributed mainly in the cytoplasm and are activated by the GTP-bound RhoA,
undergoing translocation from the cytoplasm to the membrane (Noma et al., 2006).
Rho-kinase has been implicated in actin dependent functions, such as cell motility,
formation of stress fibers, and focal adhesions, organization of the actin cytoskeleton,
and smooth muscle contraction (Shabir et al., 2004). Rho is activated by Rho-kinase
which may function in smooth muscle as a signaling molecule, activating a
mechanism that sensitizes the contractile machinery to Ca2+ (Shabir et al., 2004). The
main physiological effect of Rho- kinase is the ability to enhance actin-myosin
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association by increasing MLC phosphorylation and by preventing actin
depolymerization (Norma et al., 2006).
Inhibiting Rho-kinase has been found to reduce the plateau component of the
action potential, inhibiting the Ca2+ channels and also indirectly the Ca2+ activated er
channels (Shabir et al., 2004). Inhibition of Rho-kinase produces a Ca2+ independent
increase in the relaxation rate of muscle contraction.
Rho-kinase isoforms have been used to investigate in vivo distribution and
function through knockout mice. 'The loss of Rho-kinase in knockout mice resulted in
placental dysfunction leading to intrauterine growth retardation and fetal death
(Loirand et al., 2006). Mice that survived were found to undergo normal
development and were fertile (Loirand et al., 2006). In pressurized small arteries, the
use of Rho-kinase inhibitors has showed that the Rho-kinase pathways are active in
the absence of vasoconstrictors, acting to keep the vessels in a state of high calcium
sensitivity and basal tone (Loirand et al., 2006). The present knowledge ofRhokinase signaling has suggested that pharmacological agents which target Rho-kinase
may have a therapeutic benefit in reducing cardiovascular disease (Loirand et al.,
2006; Noma et al., 2006).

Rho-A and HSP27
Rho A has been found to regulate smooth muscle contraction through
cytoskeletal reorganization of the low molecular weight HSP27 identified as an actin
binding protein. In a variety of tissues HSP27 is expressed in the absence of stress
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and it has been suggested to have a phosphorylation-activated homeostatic function at
the actin cytoskeleton level (Wang and Bitar, 1998). In cells affected with dominant
negative Rho A, experiments with ceramide or endothelin suggested that Rho A may
exert its effects on the cytoskeletal reorganization by HSP27 (Wang and Bitar, 1998).
The requirement of Rho
A for
HSP27 red(strib,ution may be linked to the interaction
'
.,
between cytoskeletal proteins
which
are
sustained' within "a smooth muscle
.
,,
''
contraction.

Y-27632
The inhibitor Y-2763 was used to analyze the involvement of Rho and Rhoassociated kinase in the organization ofF- actin cytoskeleton within T-cells
(Rodriguex-Fernandez et al., 2001). It was found that the inhibitor Y-2763 affected
only the organization of the F-actin; in T-cell the total actin levels were not altered
(Rodriguex-Fernandez et al., 2001). The effect of the inhibitor on the cytoskeleton
was selective as the microtubules were not altered (Rodriguex-Fernandez et al.,
2001).
Y-27632 has been found to inhibit the Rho family ofkinases 100-fold more
potently than other kinases including protein kinase C, cAMP-dependent kinase, and
myosin light chain kinase (Ishizaki et al., 2000). It has been found that Y-27632
inhibits the Rho-kinases by competing with ATP for binding to the kinases, however
Y-27632 can exert specific effects at a lower µM concentration within the cells
because ATP is present within the cell at millimolar concentrations (Ishizaki et al.,
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2000). The competition between inhibition kinetics suggests that millimolar
concentrations ofY-27632 is required in order to inhibit the kinase activity of Rho in

situ within the cell (Ishizaki et al., 2000).
Y-27632 has also been used to investigate the expression of the two isoforms
of Rho-kinase and its role in the pathophysiological control of smooth muscle
contraction in rabbits. The use ofY-27632 considerably suppressed the ureter
contractile responses within the rabbits (Rodriguex-Femandez et al., 2001).
Inhibitors of Rho-kinase such as Y-27632 will have similar effects compared to
dominant-negative mutants ofRho-kinases, causing a loss of actin stress fibers and
focal adhesion complexes (Noma et al., 2006). This action is believed to be due to
phosphorylation and inhibition ofMLCP by Rho-kinases, which increase MLC
phosphorylation and cellular contractions by increasing interaction ofmyosin with
actin (Ishizaki et al., 2000).
When Y-27632 was used to examine in the role of Rho-kinase in cytokinesis,
it was found that concentrations greater than 100 µM were required for significant
inhibition. However, inhibition.did demonstrate damaging effects upon the cells
(Ishizaki et al., 2000).
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Functions of the Extracellular Matrix in Smooth Muscle
Cells contact the extracellular matrix through a variety of specialized
structures. Contact with the extracellular matrix contact allows for cell adherence and
migration. The extracellular matrix also acts as a relay station for important signaling
pathways. Integrin proteins bind both matrix components and cellular proteins,
connecting the extracellular environment and the cytoskeleton (Linder and Kopp,
2005). Proteins embedded in a ring structure of integrins and integrin associated
proteins have been named podosomes.

Podosomes
Podosomes are structures that have a half life of 2-12 minutes within the cell.
The podosome structure is composed of a ring and core which are linked by bridging
molecules such as o.~actinin, and the whole structure is surrounded by a cloud of
monomeric actin molecules (Linder and Kopp, 2005). The stability of the structure is
found in the core component of the podosome which is rich in F-actin. Also found
within a podosome are actin regulators of the Wiskott-Aldrich Syndrome protein
(WASP) family, Arp 2/3 complexs, cortactin and gelsolin. Gelsolin has been found
to contribute to the actin turnover through its ability to both sever and cap actin
filaments (Chellaiah et al., 1998). F-actin will turn over 2-3 times during the life span
of the podosome. The ring structure is composed of plaque proteins such as vinculin
or talin, and kinases such as PBK or Pyk2/FAK (Linder and Kopp, 2005). Integrins
that are anchored in the extracellular matrix are distributed over the whole outer
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surface of the podosome, but show isotype-specific localization: ~ 1 integrins will
localize mostly to the core, and ~2 and ~3 will localize to the ring (Linder and Kopp,
2005).
Podosomes are usually found in cells of the monocytic lineage, such as
macrophages, osteoclasts, or immature dendritic cells. They also may be found or
induced in a variety of other cell types such as endothelial cells, and smooth muscle
cells (Linder and Kopp, 2005). Since podosomes are formed on a soft substrate, they
are believed to be physiological structures that are formed in the context of tissue
(Linder and Kopp, 2005). A cell will usually form dozens ofpodosomes, with a
diameter of0.5-1 µMand a depth of0.2-4 µM. Individual podosomes are motile
within a certain radius, but movement of a podosome group is accomplished through
the dynamic assembly at the front and disassembly at the rear (Linder and Kopp,
2005).
The main function ofpodosomes appears to be adhesion, because they
establish close contact to the substratum. Podosome-type adhesion is mostly formed
in cells that have to cross tissue boundaries such as monocytes, immature dendritic
cells or some types of cancer cells (Linder and Kopp, 2005). Podosomes may also be
involved with cell migration. They may help with localized anchorage, stabilizing
sites of cell protrusion and enabling productive directional movement.
A variety of cellular signaling pathways influence podosomes. The major
modes ofpodosome regulation include signaling by Rho family GTPases, actin
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regulatory pathways, protein tyrosine phosphorylation, and the influence of the
microtubule system (Linder and Kopp, 2005).
Within the Rho GTPases Rho A, Rae 1, and CDC42 have all been found to
regulate podosome turnover within various cells, with their particular mode of action
depending upon the cell type.
Podosome type adhesions can be induced by the transformation of cells with
viruses whose oncongenes encode tyrosine kinases such as v-Src . Cellular tyrosine
kinases such as Src and Csk have a major role in podosome regulation (Linder and
Kopp, 2005).

A7r5 Cell Line:
The A7r5 fibroblast cell line was derived from the smooth muscle tissue
excised from the thoracic aorta of a rat embryo. The A7r5 cells produce muscle-type
isoenzymes, which include myokinase and creatine phosphophokinase. The
fibroblast produces myosin, and the activity of the isoenzymes will increase when the
culture of the A7r5 cells reach a stationary phase (Kaverina et al., 2003). The A7r5
cell line displays prominent stress fibers and focal contacts, and has also been shown
to respond to contractile stimuli (Kaverina et al., 2003). It was found that when
remodeling the a-and ~-actin domains within the A 7r5 smooth muscle cells during
PDB-induced contraction, suggests that remodeling plays a role in contractile
function (Fultz et al., 2002).
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A7r5 smooth muscle cells that were induced to contract with PDBu 12, 1, and
visualized with beta-actin EGFP, were shown to express densely packed actin stress
cables, which were arranged in parallel and extended formation across the cell body
(Fultz et al., 2003). The PDBu caused 85% of the cells to undergo contraction while
showing evidence of forcible detachment from peripheral adhesion sites (Fultz et al.,
2003).

A7r5 Cells and Podosome Formation

Podosome initiation and maintenance in A7r5 cells require Arp2/3 dependent
actin polymerization and occur preferentially in the cell periphery (Kaverina et al.,
2003). Dynamic actin remodeling may possibly occur within the central region of the
podosome. Phorbol ester is found to trigger the conversion of focal adhesions into
podosomes within the A 7r5 smooth muscle cells (Kaverina et al., 2003; Fultz et al.
2002). The outer region of the stress fiber bundle will form podosomes, at
specialized sites that are embedded into adhesion plaques at the basal surface of the
plasma membrane, and cortactin will reside constitutively at the microdomains
(Kaverina et al., 2003).
Rat smooth muscle cells will change from spear shaped to rosette like
podosomes when given PDBu(Kaveria, et al., 2003). This process can be blocked by
specific inhibitors such as PKC and Src (Hai et al., 2003; Brandt et al., 2002) and is
regulated tightly by smooth muscle specific proteins of the calponin family, which
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may act to suppress podosome formation in normal smooth muscle tissue (Kaverina,
et al., 2003).
Podosomes are representations of hot spots where there is a high actin
turnover in smooth muscle and monocytic cells, and formation of newly polymerized
actin filaments requires delivery ofG-actin subunits to the site of polymerization
(Kaverina, et al., 2003).
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METHODS

Cell Culture Procedure:
A 7r5 cell line, harvested from embryonic rat aorta and shown to exhibit adult
smooth muscle characteristics (Kaverina et al., 2003), was purchased from American
Type Culture Collection (Manasass, VA). Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% Fetal Bovine Serum (FBS), 100 units/ml penicillin
G, and 100 µg/ml streptomycin (Sigma) was used to culture the cells. The cells were
grown to approximately 85% confluence after being plated onto 75 mm2 culture
flasks. The cultures were maintained in a Napco incubator at 37 degrees Celsius
within a humidified atmosphere of 5% CO2 in air. Media was changed every two
days, with the cells split at least once a week. The splitting of A 7r5 cells required a
solution of Phosphate Buffer Saline (PBS) and Trypsin EDTA (5 g/100 ml)
(Invitrogen), prepared·at'a 9:1 ratio. The PBS solution yvas prepared by autoclaving 2
PBS tablets (Sigma) in 400 ml of distilled water. The trypsin solution was added to
the cells, following the aspiration of culture medium, and incubated for 10 minutes at
37 degrees. Frequently the flasks were agitated against the palm of hand, in order to
enhance the stripping of cells from the flask. The cells were transferred to 15 ml
conical tubes and centrifuged for 10 minutes. The supernatant was discarded and the
pellet was resuspended in 3 ml ofDMEM. After resuspension, approximately 1 ml of
the resuspended cells.was added to new flasks possessing 24 ml of the DMEM, and
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placed into the incubator at 37 degrees Celsius with 5% CO2 • The cells were fed with
10% FBS supplemented DMEM every two days.

Visualization of alpha-actin:

The A7r5 cells were plated onto 22 mm by 22 mm #1 glass coverslips, which
were placed into 6 well culture plates, and returned to the incubator for a minimum of
24 hours to allow for cell attachment and spreading. After treatment, cells were fixed
and permeabilized by adding ice cold acetone for 1 minute. The cells underwent
multiple washings (3X), with phosphate-buffered saline supplemented with 1%
Tween (PBS-T), and were incubated for 10 minutes in the blocking solution (5%
nonfat dry milk in PBS-T). The cells were then washed multiple times (3X), with
PBS-T for 5 minutes. Monoclonal smooth muscle anti-a actin antibody (clone 1A4,
Sigma) at a 1: 1000 dilution was added for one hour to the cells. After incubation the
monoclonal smooth muscle anti-a actin antibody was collected and saved for further
use. After exposure to the antibody, the cells then underwent multiple washings with
PBS-T for 5 minutes. Cover slips were then mounted on the glass slides (Fisher)
using Gel Mount (BioMedia) and then stored in the dark at 4 degrees Celsius until
observed. Slides were visualized using an Olympus 1X71 inverted fluorescent
microscope equipped with a RETIGA EXI FAST 1394 CCD camera. Images were
captured and analyzed utilizing IP lab software (Scantalytics, Fairfax, VA). Images of
the stained cells were captured at 500 millisecond exposure using the IP lab software
(Figure 4).
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PDBu stimulation of A7r5 cells
To stimulate the contraction of the A7r5 cells and podosome formation, PDBu
was added to each well to a final concentration of 10 -sM (Figure 5). Phorbol ester
was initially dissolved in DMSO and then diluted to working concentration with
distilled water. Cells were then fixed and stained as described above.

Effect ofY-27632 on resting A7r5 cells
To determine the effect of Rho kinase inhibition on resting A7r5 smooth
muscle cells, Y-27626 (lOµM) was added to resting cultures of A7r5 cells for 40
minutes (Figure 6) before fixation and staining for alpha actin.

Effect ofY- 27632 on precontracted A7r5 cells
A7r5 cells were seeded onto coverslips as described above. Cells were treated
with 10 -SM PDBu for 20 minutes to allow for contraction and podosome formation.
Three separate concentrations ofY-27632 were then added to wells in final
concentrations of lµM, 0.lµM, and lnM for twenty minutes. Cells were then fixed
and stained (Figure 7).
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Figure 4. Antibody staining protocol for visualization of alpha-actin.
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PDBu 10-8 M
20 Minutes

Fixed and
Stained

Figure 5. Protocol outline for PDBu stimulation of A 7r5 cell line.

Y-27632

1'0~

8

M

.

'

Fixed and
Stained

Figure 6. Protocol outline for Rho-kinase inhibition in unstimulated A 7r5 smooth
muscle cells.
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PDBu 10-8 M
20 Minutes •

Y-27632 1o-8 M

Fixed and
Stained

Figure 7. Protocol outline for PDBu and inhibitor stimulation of A7r5 cell line,
examining the effects ofY-27632 on precontracted A7r5 smooth muscle
cells.
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Y-27632 pretreatment with additional PDBu treatment following
A 7r5 cells were seeded onto coverslips as described above. Cells were treated
with either lµM, 0.lµM, and lnM ofY-27632 for 20 minutes to allow for inhibition
of Rho kinase before stimulation with IO -sM PDBu for 20 minutes (Figure 8). Cells
were then fixed and stained.

Time course for the effect ofY-27632 on the resting a-actin cytoskeleton
A7r5 cells were seeded onto coverslips as described above. Cells were treated
with lnM ofY-27362 for 5, 10, 20, 30 or40 minutes to allow a timecourse
visualization of the effects of Rho kinase on the resting A7r5 cell (Figure 9). Cells
were then fixed and stained.

Data Analysis
Each experiment was performed a minimum of three times with at least 50
cells from fixed preparations that were evaluated prior to the experiment. The
statistical data was analyzed by a two way ANOVA followed by a Students t-test. P
< 0.05 was considered significant.
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Y-27632
10-8 M

PBDu 10-8 M
20 Minutes

Fixed and
Stained

Figure 8. Protocol outline for A7r5 smooth muscle cells pretreated with Y-27632
before stimulation.

Y-27632 1o-8 M
5, 10,20,30, or 40 Minutes

Fixed and
· Stained

Figure 9. Protocol outline for A7r5 smooth muscle cells treated with Y-27632 before

stimulation at timed intervals of 5, 10,20,30 or 40 minutes.

- 29 -

RESULTS

Podosome formation in A 7r5 cells

To verify that our cell culture techniques allowed the A7r5 cell line's a-actin
to form podosomes, cells were stimulated with PDBu for 20 minutes. The results
confirmed that podosome formation occurred within the cells when stimulated with
PDBu, as seen in Figure 10. Podosome formation was observed within the A7r5 cell
line in greater than 90% of the cells. In vehicle control A7r5 cells 8 ± 3.19 % of the
cells demonstrated podosomes formation while 94.2 ± 16% of the A7r5 cells
stimulated with 10·8M PDBu demonstrated podosomes formation (p<.01)
Criteria for determining ifpodosomes existed within the cell was established
if the a-actin developed into structural posts that were seen in a circular pattern
throughout the cell. The top left panel in Figure 14 illustrates typical podosome
formation within the A7r5 smooth muscle cell.
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Figure 10. Alpha-actin remodeling and podosome formation in A7r5 cells. Data is
expressed as mean percent of cells undergoing a -actin remodeling and
podosorne formation.
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Inhibition ofpodosomes with Y-27632 pretreatment
A7r5 cells were pretreated for twenty minutes with Y-27632 inhibitor with
concentrations of lµM, 0.lµM, lnM. PDBu was then added to the cells at a final
concentration of 1o-8M to stimulate actin remodeling and podosomes formation.
A7r5 cells that were pretreated for 20 minutes with lµM Y-27632 demonstrated 7.3

± 1.76 % podosomes formation (Figure 11).

A7r5 cells that were pretreated for 20

minutes with 0.lµM of the inhibitor Y-27632 demonstrated 20.0 ± 5.6 podosome
formation (Figure 11). A7r5 cells that were pretreated for 20 minutes with lnM of
the inhibitor Y-27632 demonstrated 13.5 ± 4.86 % podosomes formation (Figure 11 ).

It is apparent that Rho kinase inhibition prevents alpha actin remodeling in PDButreated A7r5 cells. All three treatment concentrations were significantly different

(p<.O 1) from PDBu stimulated control cells that did not undergo Rho kinase
inhibition. A typical result showing a-actin in a cell pretreated with lµM Y-27632
and then stimulated with 10 -SM PDBu is shown in the bottom right panel of figure
12.
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Figure 11: Podosome formation in A 7r5 cells pretreated with 1µM, 0.1 µM , 1nM of
Y-27632 for twenty minutes before PDBu stimulation. Data is expressed
as mean percent of cells undergoing cx-actin remodeling and podosome
formation. (* represents significant difference p<.01 from vehicle
controls, # represents significant difference (p<.01) from PDBu
stimulated cells).
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Control

PDBu 10-SM, 20 min.

PDBu 10-SM, 20 min.
Y-27632 10 M, 20 min.

Y-27632 10µM, 20 min.
PDBu 10-SM 20 min.

Figure 12: Micrograph comparing a-actin structure in a control cell (top left) and a
cell that was treated with 10 -SM PDBu for 20 minutes (top right)
indicating remodeling of the a-actin cytoskeleton and podosome
formation. Bottom panels demonstrate the effect of Rho-kinase
inhibition after (left) and before (right) stimulation by PDBu. Original
magnification at 400x.

- 34 -

Y-27632 induced loss ofpodosome structure in precontracted A7r5
A 7r5 cells were stimulated with PDBu and then treated with Y-27632 to see

..

' '

.

'

....

if Rho kinase inhibition would destroy the podosome· structure that was previously
formed. The A7r5 cells were p~etreat~d PBDu··cio'8M, 20 niinutes) to stimulate actin
remodeling and podosomes formation and then underwent exposure to lµM, 0.lµM,
lnM of the Rho-kinase inhibitor Y-27632 following the 20 minute PDBu
pretreatment. A7r5 cells that were pretreated for 20 minutes with PDBu then lµM of
the inhibitor Y-27632 for 20 minutes demonstrated 18.1 ± 1.15 % podosomes (Figure
13). A7r5 cells that were pretreated for 20 minutes with PDBu and then 0.lµM ofY27632 for 20 minutes demonstrated 13.3 ± 4.3 % podosomes (Figure 13). A7r5 cells
that were pretreated for 20 minutes with PDBu following lnM of the inhibitor Y27632 demonstrated 13.3 ± 2.75% podosomes (Figure 13). This suggests that
podosomes formation could not be maintained after the application of the inhibitor Y27632 for 20 minutes in all three concentrations. A typical cell is that was contracted
with PDBu and then treated with l0µM Y-27632 is shown in the bottom left hand
corner of Figure 12.
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Figure 13: Podosome formation in A 7r5 cells pretreated with PDBu following 1µM
ofY-27632 for twenty minutes. Data is expressed as mean percent of
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represents significant difference p<.O 1 from vehicle controls, # represents
significant difference (p<.01) from PDBu stimulated cells).
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Effect ofY-27632 on the alpha-actin cytoskeleton in a resting cell
In order to determine if Rho kinase activity was required to maintain the
cable-like alpha-actin structure observed in resting cells, Y-27632 (lµM, 40 minutes)
was added to resting A7r5 cells (Figure 14). After forty minutes exposure to Y27632 the filamentous alpha-actin structure was lost and little evidence of cable
structure was present (Figure 14).
It was decided that a more thorough investigation of the effect ofY-27632 on

the a-actin cytoskeleton. It was decided to use the lower concentration of 1nM.
A7r5 cells were exposed to Rho-kinase inhibitor for 5, 10, 20, 30, and 40 minutes and
were then fixed and stained for a-actin (Figure 15). There was a loss of a-actin
structure apparent after five minutes exposure with significant loss of cable structure
after 30 minutes. At 40 minutes exposure there were very few cable structures
remaining suggesting that Rho kinase is essential in the maintenance of filamentous
a-actin structure.
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Control

Y-27632 10µm, 40 min.

Figure 14: Micrograph comparing a-actin structure in a control cell (left) and
a cell that was treated with 10rnM Y-27632 for 40 minutes (right)
indicating loss of a-actin cables in a resting cell. Original
magnification 400x.
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Control

5 minutes

10 minutes

20 minutes

30 minutes

40 minutes

Figure 15: Time course illustrating the effect of Rho-kinase inhibition on
resting A7r5 cells. Cells were exposed to lnM ofY-27632 for
5, 10, 20, 30, and 40 minutes. Original magnification 400x.
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DISCUSSION

A model has been developed by Li et al., (2001) that describes how
'

'

remodeling of the cytoskeleton may explain the unique properties of force
development and the maintenance of tension that occurs in smooth muscle (Figure
16). The model proposes that a resting smooth muscle cell will contain inactive
contractile proteins (a-actin and myosin II) and ~-actin stress cables. Alpha-actin and
smooth muscle specific myosin II exist as closely associated fibers in the resting cell
(Fultz and Wright, 2003). Agonist stimulation will induce early force development
by interaction of a-actin and myosin and subsequently introduce alteration in strain
distribution, which will then lead to ~-actin remodeling to a shorter configuration that
serves to hold the cell in the shortened configuration with the intention to preserve
tension development during subsequent a-actin and myosin disassembly/reassembly.
The reassembly of a-actin and myosin serves to optimize the overlap for additional
contractile activity at the shortened length. This cycle of actin and myosin
remodeling will continue during active force generation. The smooth muscle cell will
plateau in force development and the formation of a stable system of tension bearing
elements that will hold the cell in the shortened state with low expenditure of energy.
This hypothesis is supported by observations of differential remodeling of alpha- and
beta- actin (Fultz et al., 2000) and the localization of smooth muscle myosin with
alpha-actin in the A7r5 smooth muscle cell (Fultz and Wright, 2003).
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Figure 16. Model explaining force development and maintenance of active tension
in smooth muscle (Li et al., 2001).
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There has been a great interest in the role that actin has on cytoskeleton
organization within smooth muscle contractile properties. Cytochalasins are a group
of metabolites isolated from fungi (especially Helminthosporium dematioideum) that
inhibit various cell processes (Carter, 1967). It was determined that the molecular
mechanism of cytochalasins was through binding to the barbed or growing end of the
actin filament, which would then prevent the addition of a subsequent monomer and
prevent active actin remodeling (Cooper, 1987). Cytochalasins smooth muscle
contraction affecting calcium currents, myosin light chain phosphorylation, or myosin
ATPase activity within the K+ depolarized tissue (Obara and Y abu, 1994).
Cytochalasin
was used to inhibit actin polymerization
and caused a
.
.
selected blockage of a slow tension increase within rat aortic smooth muscle (Wright
and Hurn, 1994). It was suggested by Wright and Hurn (1994) that for slow tension
development to occur within smooth muscle, dynamic remodeling of a portion of the
actin cytoskeleton must occurr during the contraction. This suggestion was supported
(Mehta and Gunst, 1999) which showed an inhibition of actin polymerization by
latrunculin-A, complexes with free monomers and will then lead to an inactivation of
G-actin (Coue et al., 1987). This was found to lead to depressed force development
without having an affect upon the myosin light chain phosphorylation, which would
suggest that actin polymerization will contribute directly to force development. It
was also shown that inhibition of actin polymerization will block calcium dependent
stress relaxation within vascular smooth muscle, implicating possible active
remodeling of the actin cytoskeleton which may decrease cellular tension following
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an abrupt stretch (Wright and Battistella-Patterson, 1998). It has also been shown
that actin is dynamic in resting tissue, with polymerization/depolymerization
occurring and that stabilization may take place in the plateau of smooth muscle tissue
undergoing contraction (Barney et al., 2001). All of this together leads to the
suggestion that actin polymerization would be essential for contractile and stress
relaxant properties of smooth muscle. Blocking of polymerization can not be credited
to a simple loss in the structure of the cytoskeleton but would more likely be an
accurate reflection of the inhibition on the dynamic actin cytoskeleton remodeling
that occurs.
The long-term goal of this project is to elucidate the biochemical
mechanism(s) utilized by smooth muscle to regulate the drastic cytoskeletal
remodeling that occurs during the contraction of smooth muscle. To begin this
process, we have chosen to determine if Rho kinase inhibition will alter the dynamic
a-actin remodeling that is observed in the PDBu-stimulated A 7r5 cell.
Rho kinase has been implicated in smooth muscle contraction, is distributed
mainly within the cytoplasm, and when activated by GIP bound Rho-A

will translocate from the cytoplasm to the membrane (Noma et al., 2005). Rho-kinase
has a role in regulation of the cell contraction within smooth muscle cells, but has
also been demonstrated to be critic:tl in controlling migrat\on, proliferation, cell
apoptosis/survival, gene transcripti_on, and differentiat_ion (reviewed in Loirand et al.,
2006). The contraction of smooth n;mscle is dependent upon the balance between
myosin light chain kinase and myosin phosphatase. Rho-kinase plays an important
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role in the regulation ofmyosin phosphatase activity. RhoA and its downstream
target Rho-kinase phosphorylate the myosin-binding subunit of myosin light chain
kinase by phosphatase inhibition of the myosin light chain kinase(reviewed in Webb,
2003). When Rho-kinase is inhibited with Y-27632 it will result in relaxation of
isolated segments and smooth muscle contraction to many different agonists
(reviewed in Webb, 2003). Within animal models, Rho-kinase has been used for
treatment of the relaxation of the smooth muscle arteries, resulting in a blood pressure
lowering effect (Chitaley et al., 2001 ).
In this study we observed the effects of the Rho kinase inhibitor with Y-27632

on the very specific remodeling of the a.-actin component of the cytoskeleton in the
A 7r5 cell. In order to determine that our A 7r5 smooth muscle. cells were responsive
to phorbol ester, cells were stimulated with 1o·8M PDBu for 20 minutes. Over ninety
percent of cells evaluated demonstrated a.-actin remodeling into podosomes.
To test the hypothesis t~at Rho kinase is essential for proper a.-actin
remodeling and podosomes formation, A7r5 smooth muscle cells were treated Y27632 at three concentrations (lµM, O.lµM, and lnM) for twenty minutes prior to 10·
8

M PDBu stimulation. Results indicate that inactivation of Rho kinase prevented

podosome formation and caused a general dissolution of alpha-actin cable structure
was observed (Figures 11 ). This indicates that Rho kinase activity is required for
podosome formation and that Rho kinase may be needed for a.-actin fiber
maintenance.
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We then wanted to determine if Rho kinase activity is required in the
maintenance of podosomes in cells that are precontracted. Cells were stimulated with
PDBu for twenty minutes to allow for remodeling and podosome formation and the
effect of Rho kinase was examined by the addition of three different concentrations of
Y-27632 (lµM, 0. lµM, and lnM) for twenty minutes. Cells were observed to
undergo a loss of podosome structures and also a loss ofresidual stress cables. This
further implicates the necessity for Rho kinase activity in the podosomes structure.
Finally we wanted to observe the effect of inhibition of Rho kinase by Y27632 in the resting A7r5 smooth muscle cell line. Two concentrations ofY-27632
were utilized in this experiment. A7i5 cells exposed to lµM Y-27632 for forty
minutes demonstrated a drastic loss ofalpha-actin cable structure (Figure 13). We
then pursued a more detailed time course with a reduced level ofY-27632 (lnM).
Cells were exposed to lnM Y-27632 for 5, 10, 20, 30 and 40 minutes and
representative micrographs are presented in Figure 15. At five minutes exposure, the
disruption of the a.-actin cytoskeleton is observed with almost complete loss of cable
structure by forty minutes exposure. This data suggests that Rho kinase is necessary
for a.-actin bundling into its characteristic cable structure.
This study has provided evidence that Rho-kinase may play a role in the
signal transduction pathway that leads to a.-actin remodeling and podosome
formation and maintenance in the contracting A7r5 smooth muscle cell. We conclude
that Rho-kinase may play a critical role in a.-actin dynamics during contraction as
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well as being necessary for F-actin structure in the cell. This has implications not
only in the contraction of smooth muscle, but also in other physiological processes
that require actin remodeling such as mitosis and cell crawling. Rho-kinase is
implicated in actin dependent functions such as cell motility, formation of stress
fibers, focal adhesions and smooth muscle contraction (Shabir et al., 2004). Data
suggests (Shabir et al., 2004) that Rho-kinase may be involved as a signaling
molecule that will activate a mechanism that will sensitize the contractile machinery
to Ca2+. This study has provided information that Rho-kinase, present within the
A 7r5 smooth muscle cell line, provides a role in smooth muscle contraction and
maintenance of the contracted state at such a low energy concentration.
Further experimentation should pursue the effect ofY-27632 on the P-actin
cytoskeleton to determine if there is differential regulation of the two actin isoforms
during smooth muscle contraction. Another future experiment would be to examine
the effect of Rho-kinase inhibition by the inhibitor Y-27632 and the effect it has upon
the G-actin and F-actin ratio within smooth muscle cells upon contraction.
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